Raymond James Financial Services Advisors’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $11M | Sell |
551,887
-31,470
| -5% | -$629K | 0.01% | 824 |
|
|
2024
Q2 | $6.52M | Buy |
583,357
+322,911
| +124% | +$3.61M | 0.01% | 1029 |
|
|
2024
Q1 | $1.72M | Buy |
260,446
+28,196
| +12% | +$186K | ﹤0.01% | 1720 |
|
|
2023
Q4 | $1.05M | Sell |
232,250
-16,227
| -7% | -$73.3K | ﹤0.01% | 1949 |
|
|
2023
Q3 | $890K | Buy |
248,477
+103,464
| +71% | +$370K | ﹤0.01% | 1971 |
|
|
2023
Q2 | $535K | Sell |
145,013
-12,565
| -8% | -$46.4K | ﹤0.01% | 2308 |
|
|
2023
Q1 | $522K | Sell |
157,578
-5,119
| -3% | -$16.9K | ﹤0.01% | 2307 |
|
|
2022
Q4 | $631K | Buy |
162,697
+15,663
| +11% | +$60.8K | ﹤0.01% | 2132 |
|
|
2022
Q3 | $357K | Sell |
147,034
-93,577
| -39% | -$227K | ﹤0.01% | 2470 |
|
|
2022
Q2 | $476K | Buy |
240,611
+106,186
| +79% | +$210K | ﹤0.01% | 2303 |
|
|
2022
Q1 | $246K | Sell |
134,425
-524
| -0.4% | -$959 | ﹤0.01% | 2842 |
|
|
2021
Q4 | $190K | Buy |
134,949
+25,912
| +24% | +$36.5K | ﹤0.01% | 2983 |
|
|
2021
Q3 | $123K | Buy |
109,037
+34,080
| +45% | +$38.4K | ﹤0.01% | 3080 |
|
|
2021
Q2 | $120K | Sell |
74,957
-453
| -0.6% | -$725 | ﹤0.01% | 3106 |
|
|
2021
Q1 | $133K | Buy |
75,410
+34,408
| +84% | +$60.7K | ﹤0.01% | 2996 |
|
|
2020
Q4 | $80K | Buy |
41,002
+1,202
| +3% | +$2.35K | ﹤0.01% | 2866 |
|
|
2020
Q3 | $95K | Sell |
39,800
-1,925
| -5% | -$4.6K | ﹤0.01% | 2687 |
|
|
2020
Q2 | $122K | Buy |
+41,725
| New | +$122K | ﹤0.01% | 2590 |
|
|
2018
Q4 | – | Sell |
-23,700
| Closed | -$147K | – | 2545 |
|
|
2018
Q3 | $147K | Buy |
23,700
+8,800
| +59% | +$54.6K | ﹤0.01% | 2601 |
|
|
2018
Q2 | $67K | Buy |
+14,900
| New | +$67K | ﹤0.01% | 2641 |
|